Clinical

Dataset Information

0

Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer

ABSTRACT: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of bryostatin 1 in treating patients with metastatic colorectal cancer.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2002785 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Clinical Flavopiridol in Treating Patients With Refractory Cancer
| 2006388 | ecrin-mdr-crc
Clinical Irinotecan in Treating Patients With Colorectal Cancer
| 2003322 | ecrin-mdr-crc
Clinical Pyroxamide in Treating Patients With Advanced Cancer
| 2008028 | ecrin-mdr-crc
Clinical Irofulven in Treating Patients With Metastatic Colorectal Cancer
| 2002970 | ecrin-mdr-crc
Clinical Irinotecan in Treating Patients With Metastatic Colorectal Cancer
| 2003060 | ecrin-mdr-crc
Clinical Gemcitabine in Treating Patients With Advanced Colorectal Cancer
| 2005648 | ecrin-mdr-crc
Clinical BMS-247550 in Treating Patients With Metastatic Colorectal Cancer
| 2007345 | ecrin-mdr-crc
Clinical VNP40101M in Treating Patients With Advanced or Metastatic Cancer
| 2008496 | ecrin-mdr-crc
Clinical DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer
| 2006725 | ecrin-mdr-crc
Clinical Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
| 2006232 | ecrin-mdr-crc